These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 30852037)

  • 1. Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
    Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
    J Vasc Surg; 2019 Jun; 69(6):1840-1847. PubMed ID: 30852037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
    Kodama A; Meecham L; Popplewell M; Bate G; Conte MS; Bradbury AW
    Eur J Vasc Endovasc Surg; 2020 Nov; 60(5):687-695. PubMed ID: 32778491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Contemporary Clinical Outcomes Following Femoro-Popliteal Plain Balloon Angioplasty and Bypass Surgery for Chronic Limb Threatening Ischemia.
    Meecham L; Popplewell MA; Bate GR; Patel S; Bradbury AW
    Vasc Endovascular Surg; 2021 Aug; 55(6):544-550. PubMed ID: 33882737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of femoropopliteal plain balloon angioplasty for chronic limb-threatening ischemia in the BASIL trial and in a UK contemporary series.
    Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
    J Vasc Surg; 2021 Dec; 74(6):1948-1955. PubMed ID: 34298121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Immediate and Long-term Outcomes in Men and Women Undergoing Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL-1) Trial.
    Benson RA; Meecham LA; Hewitt CA; Bradbury AW
    Eur J Vasc Endovasc Surg; 2019 Aug; 58(2):224-228. PubMed ID: 31201136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.
    Perlander A; Jivegård L; Nordanstig J; Svensson M; Österberg K
    J Vasc Surg; 2020 Dec; 72(6):1987-1995. PubMed ID: 32276010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT.
    Moakes CA; Bradbury AW; Abdali Z; Bate GR; Hall J; Jarrett H; Kelly L; Kigozi J; Lockyer S; Meecham L; Patel S; Popplewell M; Slinn G; Deeks JJ;
    Health Technol Assess; 2024 Oct; 28(65):1-72. PubMed ID: 39397484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.
    Giles KA; Farber A; Menard MT; Conte MS; Nolan BW; Siracuse JJ; Strong MB; Doros G; Venermo M; Azene E; Rosenfield K; Powell RJ
    J Vasc Surg; 2024 Nov; 80(5):1515-1524. PubMed ID: 38908805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Clinical Outcomes Following Femoropopliteal Bypass or Plain Balloon Angioplasty with Selective Bare Metal Stenting in the Bypass Versus Angioplasty in Severe Ischaemia of the Limb (BASIL) Trial.
    Meecham L; Bate G; Patel S; Bradbury AW
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):52-59. PubMed ID: 30786974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular Therapy Provides Similar Results of Bypass Graft Surgery in the Treatment of Infrainguinal Multilevel Arterial Disease in Patients with Chronic Limb-Threatening Ischemia in All GLASS Stages.
    Casella IB; Sartori CH; Faustino CB; Vieira Mariz MP; Presti C; Puech-Leão P; De Luccia N
    Ann Vasc Surg; 2020 Oct; 68():400-408. PubMed ID: 32339688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Outcomes Following Infrapopliteal Plain Balloon Angioplasty in the BASIL Trial (1999-2004) and in a Contemporary Series (2009-2013).
    Popplewell MA; Davies HOB; Renton M; Bate G; Patel S; Deeks JJ; Bradbury AW
    Vasc Endovascular Surg; 2020 Feb; 54(2):141-146. PubMed ID: 31749415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedural and 12-month in-hospital costs of primary infra-popliteal bypass surgery, infrapopliteal best endovascular treatment, and major lower limb amputation for chronic limb threatening ischemia.
    Popplewell MA; Andronis L; Davies HOB; Meecham L; Kelly L; Bate G; Bradbury AW
    J Vasc Surg; 2022 Jan; 75(1):195-204. PubMed ID: 34481898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Limb Salvage and Amputation-Free Survival After Femoropopliteal Bypass and Femoropopliteal PTA for Critical Ischemia in a Clinical Cohort.
    Altreuther M; Mattsson E
    Vasc Endovascular Surg; 2019 Feb; 53(2):112-117. PubMed ID: 30803415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Outcomes in Patients with Infrapopliteal Disease Randomised to Vein Bypass or Plain Balloon Angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial.
    Popplewell MA; Davies HOB; Narayanswami J; Renton M; Sharp A; Bate G; Patel S; Deeks J; Bradbury AW
    Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):195-201. PubMed ID: 28602580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.
    Bradbury AW; Moakes CA; Popplewell M; Meecham L; Bate GR; Kelly L; Chetter I; Diamantopoulos A; Ganeshan A; Hall J; Hobbs S; Houlind K; Jarrett H; Lockyer S; Malmstedt J; Patel JV; Patel S; Rashid ST; Saratzis A; Slinn G; Scott DJA; Zayed H; Deeks JJ;
    Lancet; 2023 May; 401(10390):1798-1809. PubMed ID: 37116524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of foot infection on infrainguinal bypass outcomes in patients with chronic limb-threatening ischemia.
    Mayor JM; Valentin W; Sharath S; Barshes NR; Chung J; Kougias P; Mills JL
    J Vasc Surg; 2018 Dec; 68(6):1841-1847. PubMed ID: 30064844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    Simons JP; Schanzer A; Flahive JM; Osborne NH; Mills JL; Bradbury AW; Conte MS
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S120-S134.e3. PubMed ID: 31151867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scores.
    Moxey PW; Brownrigg J; Kumar SS; Crate G; Holt PJ; Thompson MM; Jones KG; Hinchliffe RJ
    J Vasc Surg; 2013 Jan; 57(1):1-7. PubMed ID: 23040797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Raab G; Ruckley CV
    Health Technol Assess; 2010 Mar; 14(14):1-210, iii-iv. PubMed ID: 20307380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.